Rifaximin in treatment of patients with Irritable bowel syndrome
Turk J Gastroenterol
.
2017 Jan;28(1):77-78.
doi: 10.5152/tjg.2016.25122016.
Authors
Bhupinder Romana
1
,
Veysel Tahan
Affiliation
1
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA. tahanv@health.missouri.edu.
PMID:
28134620
DOI:
10.5152/tjg.2016.25122016
No abstract available
Publication types
Comment
MeSH terms
Gastrointestinal Agents*
Humans
Irritable Bowel Syndrome*
Treatment Outcome
Substances
Gastrointestinal Agents